首页> 外文期刊>The Internet Journal of Nuclear Medicine >Usefulness of Tc99m HMPAO Labeled Leukocyte Scintigraphy in differentiating Splenic Abscess from Infarct
【24h】

Usefulness of Tc99m HMPAO Labeled Leukocyte Scintigraphy in differentiating Splenic Abscess from Infarct

机译:Tc99m HMPAO标记的白细胞闪烁显像在区分脾脏脓肿和梗塞中的作用

获取原文
       

摘要

Radionuclide labeled leukocyte studies are routinely performed in the evaluation of patients with fever of unknown origin and occult infections. Cerebral perfusion agent Tc99m hexamethylpropyleneamine oxime (Tc99m — HMPAO) is one of the radiopharmaceuticals widely used for labeling of mixed leukocytes. It is a lipophilic agent which crosses cell membranes readily and preferentially labels granulocytes. This mechanism is used for labeling of leukocytes. Tc99m labeled leukocytes normally accumulate in spleen by sequestration. At sites of acute infection, focal increased radiotracer labeled leukocyte uptake is seen. Hence, focal defects in spleen represent infarcts. We present in this report two cases of splenic infarct diagnosed by Tc99m HMPAO labeled leukocytes. Introduction Tc99m HMPAO labeled leukocytes accumulate in foci of acute infectious processes. Acute pyrogenic infections are usually associated with elevated neutrophil counts. Various infections that localize radiolabeled leukocytes include osteomyelitis and other orthopedic infections as well as intra abdominal, renal, cardiovascular and pulmonary infections. Since the introduction of labeling of leukocytes by Tc99m HMPAO by Peters et al (1) till now, it has also proven very efficacious in the evaluation of occult infectious processes. In addition, Tc99m HMPAO labeled leukocytes play an important role in the diagnosis of non-infectious etiology of fever of unknown origin. Use of Tc99m HMPAO in the evaluation of cerebral infarcts is well known. Here we present two cases of splenic infarct diagnosed by Tc99m HMPAO labeled leukocytes. Materials And Methods Leukocyte labeling and Imaging techniquesLeukocyte labeling of Tc99m HMPAO is performed using standard labeling methods (1,2,3). 10mci of Tc99m HMPAO labeled leukocytes were injected intravenously. Whole body and spot images were obtained at 4 and 24 hours using a GE dual head gamma camera equipped with a low energy high resolution collimator with 140 keV and a 15 % window. Case Illustrations Case 141 y/o paraplegic male presented with sepsis and fever of unknown origin. A Computed tomography (CT) of the abdomen demonstrated a multiple hypodense lesions throughout the spleen likely representing abscesses. A follow-up ultrasound indicated intrasplenic infarction with a hematoma, necrotic tissue and/or infected collection. A radiolabeled leukocyte study was requested to differentiate an abscess versus infarct in the spleen.Case 2A 37 y/o male status post pancreas renal transplant presented with fever. A CT scan reported a peripheral hypodensity in the posterior spleen suspicious for infection or an infarct. A radiolabeled leukocyte study was requested to localize the source of infection.
机译:放射性核素标记的白细胞研究通常在评估来历不明的发烧和隐匿性感染的患者中进行。脑灌注剂Tc99m六甲基丙胺肟(Tc99m-HMPAO)是广泛用于混合白细胞标记的放射性药物之一。它是一种亲脂性试剂,可轻松穿过细胞膜并优先标记粒细胞。该机制用于白细胞的标记。 Tc99m标记的白细胞通常通过螯合积聚在脾脏中。在急性感染部位,可见放射性示踪剂标记的白细胞吸收灶性增加。因此,脾的局灶性缺损代表梗塞。我们在本报告中介绍了由Tc99m HMPAO标记的白细胞诊断出的两例脾梗塞。简介Tc99m HMPAO标记的白细胞聚集在急性感染过程的病灶中。急性热原性感染通常与中性粒细胞计数升高有关。定位放射性标记的白细胞的各种感染包括骨髓炎和其他骨科感染,以及腹内,肾脏,心血管和肺部感染。自Peters等人(1)引入Tc99m HMPAO对白细胞进行标记以来(1),它在隐匿感染过程的评估中也被证明非常有效。此外,Tc99m HMPAO标记的白细胞在诊断未知来源的发热的非感染性病因中起着重要作用。 Tc99m HMPAO在评估脑梗死中的应用是众所周知的。在这里,我们介绍了由Tc99m HMPAO标记的白细胞诊断出的两例脾梗塞。材料和方法白细胞标记和成像技术Tc99m HMPAO的白细胞标记使用标准标记方法(1,2,3)进行。静脉注射10mci Tc99m HMPAO标记的白细胞。使用配有140 keV和15%窗口的低能高分辨率准直仪的GE双头伽马相机在4和24小时获得全身和点图像。病例插图病例141岁的截瘫男性患有败血症和不明原因的发烧。腹部计算机断层扫描(CT)显示整个脾脏内有多个低密度病变,可能代表脓肿。后续超声检查表明脾内梗死伴有血肿,坏死组织和/或受感染的集合。要求进行放射性标记的白细胞研究以区分脓肿与脾梗死。病例2A胰腺肾移植术后发热的男性状态为37岁。 CT扫描报告可疑感染或梗死的后脾脏周围低密度。要求进行放射性标记的白细胞研究以定位感染源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号